Cleared Traditional

GlassBone Granules (K242782) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K242782 · Noraker · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2024
Decision
98d
Days
Class 2
Risk

K242782 is an FDA 510(k) clearance for the GlassBone Granules. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Noraker (Lyon, FR). The FDA issued a Cleared decision on December 23, 2024 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Noraker devices

Submission Details

510(k) Number K242782 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 2024
Decision Date December 23, 2024
Days to Decision 98 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 122d · This submission: 98d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 201
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K242782.
BonVie+
K250346 · Elute, Inc. · Feb 2025
Moldable Bone Void Filler and Moldable Bone Void Filler + CCC
K241555 · Rti Surgical, Inc. · Feb 2025
Mastergraft Matrix EXT
K243706 · Medtronic Sofamor Danek, Inc. · Jan 2025
OsteoFlo HydroFiber
K242797 · SurGenTec, LLC · Dec 2024
BioSphere Putty
K241167 · Synergy Biomedical · Dec 2024
Porous Biologic Scaffold
K240765 · Ventris Medical · Dec 2024